Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changgui Li

Showing results (141-150 of 256) with videos related to

Pageof 26
Sort By:
Cell Cycle (Georgetown, Tex.)|December 1, 2009
Spontaneous bone loss in RIP-iNOS transgenic mouse: a mouse model for diabetes-mediated osteopenia/osteoporosisQing-Sheng Mi, Sheng-Li Yan, Zai-Zhao Wang, et al.
Nanoscale|July 26, 2022
Dual photothermal nanocomposites for drug-resistant infectious wound managementChanggui Li, Jiaru Xian, Jixuan Hong, et al.
Vaccine|June 13, 2019
Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in miceAbenaya Muralidharan, Marsha S Russell, Louise Larocque, et al.
Plos One|March 7, 2012
Polymorphisms in the presumptive promoter region of the SLC2A9 gene are associated with gout in a Chinese male populationChanggui Li, Nan Chu, Binbin Wang, et al.
Scientific Reports|November 11, 2018
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infectionAbenaya Muralidharan, Marsha Russell, Louise Larocque, et al.
BMC Infectious Diseases|December 18, 2025
Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase III, double-blind, randomized, controlled trialLiwei Shi, Xuefen Gao, Lili Huang, et al.
Human Vaccines & Immunotherapeutics|November 28, 2022
Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trialDandan Zhu, Yuansheng Hu, Zhiwei Jiang, et al.
Scientific Reports|August 14, 2019
PD-1 of Sigmodon hispidus: Gene identification, characterization and preliminary evaluation of expression in inactivated RSV vaccine-induced enhanced respiratory diseaseAbenaya Muralidharan, Louise Larocque, Marsha Russell, et al.
Systematic Reviews|April 6, 2021
Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic reviewCan Wang, Xufei Luo, Maichao Li, et al.
Diabetes|April 22, 2020
Hyperuricemia Predisposes to the Onset of Diabetes via Promoting Pancreatic β-Cell Death in Uricase-Deficient Male MiceJie Lu, Yuwei He, Lingling Cui, et al.
Pageof 26

Showing results (141-150 of 256) with videos related to

Sort By:
Pageof 26
Cell Cycle (Georgetown, Tex.)|December 1, 2009
Spontaneous bone loss in RIP-iNOS transgenic mouse: a mouse model for diabetes-mediated osteopenia/osteoporosisQing-Sheng Mi, Sheng-Li Yan, Zai-Zhao Wang, et al.
Nanoscale|July 26, 2022
Dual photothermal nanocomposites for drug-resistant infectious wound managementChanggui Li, Jiaru Xian, Jixuan Hong, et al.
Vaccine|June 13, 2019
Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in miceAbenaya Muralidharan, Marsha S Russell, Louise Larocque, et al.
Plos One|March 7, 2012
Polymorphisms in the presumptive promoter region of the SLC2A9 gene are associated with gout in a Chinese male populationChanggui Li, Nan Chu, Binbin Wang, et al.
Scientific Reports|November 11, 2018
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infectionAbenaya Muralidharan, Marsha Russell, Louise Larocque, et al.
BMC Infectious Diseases|December 18, 2025
Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase III, double-blind, randomized, controlled trialLiwei Shi, Xuefen Gao, Lili Huang, et al.
Human Vaccines & Immunotherapeutics|November 28, 2022
Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trialDandan Zhu, Yuansheng Hu, Zhiwei Jiang, et al.
Scientific Reports|August 14, 2019
PD-1 of Sigmodon hispidus: Gene identification, characterization and preliminary evaluation of expression in inactivated RSV vaccine-induced enhanced respiratory diseaseAbenaya Muralidharan, Louise Larocque, Marsha Russell, et al.
Systematic Reviews|April 6, 2021
Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic reviewCan Wang, Xufei Luo, Maichao Li, et al.
Diabetes|April 22, 2020
Hyperuricemia Predisposes to the Onset of Diabetes via Promoting Pancreatic β-Cell Death in Uricase-Deficient Male MiceJie Lu, Yuwei He, Lingling Cui, et al.
Pageof 26